4.8 Article

PIPKIγ Regulates β-Catenin Transcriptional Activity Downstream of Growth Factor Receptor Signaling

Journal

CANCER RESEARCH
Volume 71, Issue 4, Pages 1282-1291

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-10-2480

Keywords

-

Categories

Funding

  1. NIH [GM057549, GM051968, CA104708]

Ask authors/readers for more resources

Increased beta-catenin transcriptional activity downstream of the Wnt/Wingless signaling pathway has been observed in many human tumors, most notably colorectal carcinomas. However, beta-catenin activation is also observed in many human malignancies with no observable Wnt activity. Wnt-independent pathways that activate beta-catenin remain undefined, yet have the potential to play a significant role during tumorigenesis. Here, we report that phosphotidylinositol phosphate kinase I gamma (PIPKI gamma), an enzyme that generates phosphoinositide messengers in vivo, directly associates with beta-catenin and increases beta-catenin activity downstream of growth factor stimulation. PIPKI gamma expression and kinase activity enhance beta-catenin phosphorylation on residues that promote nuclear importation and transcriptional activity. Lastly, we show that beta-catenin is required for PIPKI gamma-dependent increased cell proliferation. These results reveal a novel mechanism in which PIPKI gamma expression and catalytic activity enhance beta-catenin nuclear translocation and expression of its target genes to promote tumorigenic phenotypes. Cancer Res; 71(4); 1282-91. (C) 2011 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available